knowledge -WSS

knowledge

author：Wikipedia 2025-09-27 12:57:13 - browse：31

Portrait of Suhas Gondi. -- health coverage from STAT — Suhas Gondi of Brigham and Women's Hospital has researched and written about hospital boards increasingly being made up of private equity executives and others from outside medicine. Jonathan Wiggs/Globe Staff

Discontent among Mass General Brigham doctors had been at a slow burn for years. But when an unexpected announcement from the chief executive titled “A message about our future” popped into inboxes one morning last month, that frustration seemed to fully ignite.

Mass General Brigham, a dominant force in Boston medicine, was launching the latest and perhaps most contentious step in its ongoing effort to merge its two flagship Harvard-affiliated medical centers: combine all departments and divisions at both hospitals in a move that executives argued would improve patient care and access.

But after years of feeling shut out of decisions amid grinding work schedules, many doctors worried the changes would lead to layoffs, demotions, and an even greater loss of autonomy. During an online ‘‘town hall’’ on April 4, they inundated leaders with skeptical questions. One physician asked how executives planned to build trust with faculty when so many felt “unheard, devalued, disempowered, and unseen.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Covid hospitalizations on the rise, Humana says

focus

WSS

Why does health care cost so much? A reading guide

Illumina names Agilent executive as new CEO

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Crinetics acromegaly drug succeeds in late

AstraZeneca chief proposes a novel edit to the drug pricing bill

The 10 drugs up first for Medicare price negotiation

explore

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

In age of alternative facts, a scholarly course on calling out crap

Exact Sciences stock tumbles despite strong cancer detection sales

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FTC falls short on scrutinizing hospital mergers, study says

How to save PrEP access — and even expand it

Cell therapy fails to slow type 1 diabetes, but safety is established

23andMe had bad news about my health. I wish a person had delivered it

Cholera vaccine supply gets boost as demand surges globally

Apple is now the first public company to be valued at $3 trillion

Orangutan used medicinal plant to treat wound, first time ever seen

hotspot

Bird flu outbreak in cows is latest avian flu curveball

How to fix cancer clinical trials' diversity problem

Health care needs a new profession: neuroimaging counseling

Crinetics acromegaly drug succeeds in late

What American doctors can learn from their Israeli counterparts

MultiPlan and major insurers sued for alleged medical price

focus

entertainment

hotspot

knowledge